Certifications 2

Safety Data Sheet
Report No.: TCT200304M008 Page 10 of 15
Hotline: [phone] Tel: [phone] Fax: [phone] http://www.tct-lab.com
(b) Information on toxicological effects
Symptoms
Erythema (skin redness). May cause redness and tearing of the eyes. Itching.
Rashes. Hives.
(c) Delayed and immediate effects as well as chronic effects from short and long-term exposure
Sensitization:
May cause sensitization of susceptible persons. May cause sensitization by skin
contact.
Mutagenic Effects:
No information available.
Carcinogenicity:
The table below indicates whether each agency has listed any ingredient as a
carcinogen.
Chemical Name
ACGIH
IARC
NTP
OSHA
Lithium Cobalt Oxide
(CoLiO2)
12190-79-3
A3
Group 2B
X
Nickel
7440-02-0
Group 2B
Reasonably Anticipated
X
ACGIH (American Conference of Governmental Industrial Hygienists)
A3 - Animal Carcinogen
IARC (International Agency for Research on Cancer)
Group 2B - Possibly Carcinogenic to Humans
NTP (National Toxicology Program)
Reasonably Anticipated - Reasonably Anticipated to be a Human Carcinogen
OSHA (Occupational Safety and Health Administration of the US Department of Labor)
X - Present
Reproductive Toxicity
No information available.
STOT - single exposure
No information available.
STOT - repeated
exposure
Causes damage to organs through prolonged or repeated exposure. Based on
classification criteria from the 2012 OSHA Hazard Communication Standard (29 CFR
1910.1200), this product has been determined to cause systemic target organ toxicity
from chronic or repeated exposure. (STOT RE).
Chronic Toxicity
Contains a known or suspected carcinogen. Avoid repeated exposure. Prolonged
exposure may cause chronic effects. May cause adverse liver effects.
Target Organ Effects
Respiratory system. Eyes. Skin. Gastrointestinal tract (GI). Central Vascular System
(CVS).Kidney. Liver. Lungs. Heart.
Aspiration Hazard
No information available.
(d) Numerical measures of toxicity Product Information
The following values are calculated based on
chapter 3.1 of the GHS document
ATEmix (oral):
2,784.00 mg/kg
ATEmix (dermal):
1,671.00 mg/kg (ATE)